1) Graft versus host disease
移植抗宿主病
2) Graft versus host disease
移植物抗宿主病
1.
Preliminary experiences on the treatment graft versus host disease after liver transplantation;
肝移植术后移植物抗宿主病治疗的初步经验(附2例报道)
2.
Objective To determine the expression of integrin-linked kinase(ILK) in renal tissue of mice with chronic graft versus host disease(cGVHD) lupus nephritis and its relationship with the epithelial-mesenchymal transition.
目的观察整合素连接激酶(ILK)在慢性移植物抗宿主病(cGVHD)狼疮样小鼠肾脏中的表达,探讨其在狼疮肾炎肾小管上皮细胞转分化中的作用。
3.
Objective: To specifically inhibit the graft versus host disease(GVHD) and keep graft versus leukemia(GVL) effect of bone graft through selective deletion of alloreactive lymphocytes from haematopoietic stem cell grafts.
目的:选择性去除骨髓移植物中异基因反应性淋巴细胞,特异性抑制移植物抗宿主病(graft versus host disease,GVHD)并保留移植物的抗白血病(graft versus leukemia,GVL)作用。
3) graft-versus-host disease
移植物抗宿主病
1.
Inhibition effect of rapamycin on acute graft-versus-host disease after allogeneic bone marrow transplantation in a murine model;
雷帕霉素抑制小鼠骨髓移植后移植物抗宿主病作用的初步研究
2.
Role of paternal veto cells in preventing graft-versus-host disease after HLA-haploidentical stem cell transplantation in mice;
父方否决细胞对小鼠半相合干细胞移植模型移植物抗宿主病的预防作用
3.
Experimental study on the prevention of mouse graft-versus-host disease by delayed sequential transplantaton;
延迟连续移植预防小鼠移植物抗宿主病的实验研究
4) aGVHD
移植物抗宿主病
1.
This study was aimed to explore the relationship between changes of IL-4,IL-6 levels in blood plasma of patients receiving allo-HSCT and aGVHD through dynamical detection.
本研究旨在通过动态观察异基因造血干细胞移植患者血浆中IL-4和IL-6含量的变化,探讨其变化与急性移植物抗宿主病(aGVHD)发生的关系。
2.
AIM:To explore a new approach of preventing and treating of aGVHD by investigating the incidence and severity of aGVHD after allogeneic bone marrow transplantation (Allo-BMT) of the Fludarabine preserved cells of donor Rats.
目的:通过观察供鼠细胞经氟达拉滨(Fludarabine)处理后进行同种异基因骨髓移植(Allo-BMT)对急性移植物抗宿主病(aGVHD)发生率及严重程度的影响,为临床防治aGVHD探寻新的方法。
5) GVHD
移植物抗宿主病
1.
The objective of this study was to explore the occurrence and clinical features of acute graft versus host disease(aGVHD)in non-myeloablative stem cell transplantation(NAST).
本研究探讨非清髓异基因造血干细胞移植(non-myeloablative allogeneic stem cell transplantation,NAST)治疗血液病时急性移植物抗宿主病(aGVHD)的发生情况及临床特点。
2.
This study was aimed to explore the effect of ex vivo chemical modification of graft cells with methoxy polyethylene glycol (mPEG) on graft versus host disease (GVHD) after haploidentical stem cell transplantation in neonatal mice and its influence on activity of the stem cells.
本研究探讨甲氧基聚乙二醇(mPEG)化学修饰移植物细胞对小鼠单倍体相合干细胞移植后移植物抗宿主病(GVHD)的影响。
3.
Methods Seven patients with acute/chronic leukemia received HLA completely matched URD-PBSCT following conditioning regimens with cyclophosphamide(Cy)/TBI in 4 cases or busulfan(Bu)/Cy in 3 cases and prophylactic preventing graft-versus-host disease(GVHD) with cyclosporine A(CsA)/methotrexate(MTX)/Mycophenolate mofetil(MMF)/ATG(Thymoglobuline) in 7 cases from Januar.
采用环孢菌素A加骁悉加MTX加ATG(即复宁)预防性控制移植物抗宿主病。
补充资料：低血磷性抗维生素D佝偻病
低血磷性抗维生素D佝偻病
hypophosphatemic D?resistant rickets;familial hypophosphatemia
又称“家族性低磷血症”。由于原发性肾小管上皮细胞刷状缘及肠道对磷的转运障碍，致尿磷增加、血磷降低，引起佝偻病。X连锁显性遗传，多数有家族性，少数为散发。常在周岁后出现佝偻病症候，2～3岁后仍有活动性佝偻病表现。对常规治疗剂量维生素D无反应，若用大剂量维生素D或1，25-(OH）2D3和磷酸盐联合治疗可有改善。应定期测尿内钙和肌酸酐(mg/24h），尿钙/肌酸酐的正常值为0.15～0.3。调节药物剂量，以预防血钙过高。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条